Company intelligence / Profile preview
Balanced Pharma
Cornelius, North Carolina, United Statesbalancedpharma.com ↗
- Ownership
- Private
- Employees
- ~11
- Development stage
- Other
01
Overview
Balanced Pharma develops proprietary pH-balanced injectable anesthetic formulations and drug delivery devices aimed at making dental injections less painful and more reliable. Their lead products target both dental anesthesia ("Libracaine", BPI‑001) and post-surgical analgesia ("Enduracaine", BPI‑004), with the latter aiming to provide up to three days of non-opioid pain relief after procedures. All products are currently in development; no clinical trial results or regulatory approvals have been announced as of June 2025.
- Therapeutic areas
- DermatologyCardiovascularWomen's HealthOther
- Modalities
- Small moleculeDevice
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Septodont (strategic investment and board seat)
Beyond the preview
Go deeper on Balanced Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Balanced Pharma.